SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 63 filers reported holding SATSUMA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $0 | -100.0% | 93 | -94.8% | 0.00% | – |
Q2 2021 | $13,000 | +85.7% | 1,774 | +43.5% | 0.00% | – |
Q1 2021 | $7,000 | +40.0% | 1,236 | +25.2% | 0.00% | – |
Q4 2020 | $5,000 | – | 987 | +8125.0% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 12 | -96.3% | 0.00% | – |
Q1 2020 | $6,000 | 0.0% | 321 | +6.6% | 0.00% | – |
Q4 2019 | $6,000 | – | 301 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 870,820 | $13,071,000 | 14.74% |
RA Capital Management | 4,681,858 | $70,275,000 | 4.19% |
Cormorant Asset Management, LP | 858,382 | $12,884,000 | 0.78% |
Monashee Investment Management LLC | 62,500 | $938,000 | 0.43% |
TPG Group Holdings (SBS) Advisors, Inc. | 3,771,878 | $56,616,000 | 0.42% |
DC Investments Management, LLC | 35,502 | $533,000 | 0.31% |
Eventide Asset Management | 425,000 | $6,379,000 | 0.21% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 610,000 | $9,156,000 | 0.02% |
Weiss Asset Management LP | 14,150 | $212,000 | 0.02% |
Zimmer Partners, LP | 100,000 | $1,501,000 | 0.02% |